Drugs & Side Effects | COX-2 / Arthritis

Vioxx News

Vioxx Study Retraction Issued by New England Journal of Medicine

RSS News Feeds
Drugs & Pharmacuticals
Stroke
Vioxx
 All RSS Feeds

At a glance:

The New England Journal of Medicine has issued a correction with regard to a study on the heart risks of Vioxx. 
 
The study, released in 2005 and funded by Merck, the drug company that made Vioxx, concluded that the risks of heart attack began only after 18 months of Vioxx treatment.  
 
A followup study, however, adds more data which suggests that the risk begins after only 4 to 6 months. 
 
The New England Journal of Medicine thus retracted claims relating to the timing of heart damage when taking Vioxx. 
 
The finding has significance for Vioxx liability litigation, and also for people still taking other Cox-2 inhibitors such as Celebrex.

Journal Corrects Vioxx Article to Reflect Short-Term Heart Risk

Lex 18 - 6/27/2006 10:11 PM

MONDAY, June 26 (HealthDay News) -- The New England Journal of Medicine on Monday issued a rare correction on a influential 2005 study on the now-withdrawn painkiller Vioxx.
 
The correction involves a crucial point that was first reported a month ago: That cardiovascular risks linked to the controversial cox-2 inhibitor kick in at 4 months to 6 months of use, not after 18 months as was previously asserted in last year's article
 
· Read The Full Vioxx Article From Lex 18 -->

· Read All Vioxx (Rofecoxib) News Stories -->

Comments On Vioxx News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: